Tuesday, December 9, 2014
CAPITAL SUITE ROOMS 2–4
Physiological and biochemical responses to fluid bolus therapy with 4% versus 20% human albumin solution in critically ill adults
J Bannard-Smith, N Glassford, P Alexander, MJ Chan, BT Wong, M Lee, G Crawford, M Bailey, R Bellomo
The novel biased apelin receptor agonist MM07 is a potent inotrope and vasodilator in vivo
AL Brame, JJ Maguire, A Dyson, M Singer, IB Wilkinson, AP Davenport
Healthcare cost trajectories before and after critical illness: a national data linkage cohort study
NI Lone, TS Walsh
Glucose-insulin-potassium infusion for non-ischaemic cardiogenic shock: a proof of concept study
TAC Snow, M Singer
P4 immunotherapy augments phagocyte bacterial killing in patients admitted to critical care with severe community-acquired pneumonia (abstract not available)
B Morton, S Gore, M Bangert, E Dearing, R Parker, ID Welters, A Wright, G Rajam, EW Ades, A Kadioglu, SB Gordon
Superantigens in sepsis: effective treatment of staphylococcal enterotoxin B intoxication in the mouse (abstract not available)
S Whitfield, C Green, J Risdall, C Taylor, A Carter, G Griffiths
